A multi-type programmed cell death gene signature predicts survival and reveals therapeutic targets in osteosarcoma
Year: 2025
Type: article
Abstract: BACKGROUND: Osteosarcoma (OS) is an aggressive bone tumor with poor outcomes in advanced stages. Programmed cell death (PCD) plays a crucial role in tumor biology, but the prognostic value of integrating multiple PCD-related genes in OS remains underexplored. METHODS: Transcriptomic data from GEO and clinical data from TARGET were analyzed. Functional enrichment, N6-methyladenosine (m6A)-related genes analysis and immune checkpoint analyses were performed. Genes related to 18 types of PCD were intersected with OS-specific differentially expressed genes. Prognostic genes were identified by Kaplan-Meier and Cox regression. A LASSO model was developed to construct a survival prediction signature. Single-cell RNA-seq data were used to explore gene expression across cell types. RESULTS: There are 781 differentially expressed genes totally. M6A-related genes including ALKBH3, CBLL1 and immune checkpoints including HAVCR2, PDCD1 showed differential expression in OS. Twelve PCD-related genes were significantly associated with OS survival. A four-gene (FUCA1, GM2A, MAN2B1, COL13A1) prognostic model was established, showing strong predictive performance (3-year AUC = 0.801; 5-year AUC = 0.842). Lysosome-dependent cell death, apoptosis and anoikis emerged as key PCD pathways in OS. Single-cell analysis revealed COL13A1 expression in malignant cells while GM2A and FUCA1 were enriched in macrophages. CONCLUSION: This study identifies a robust PCD-related prognostic model for OS and highlights key genes and pathways involved in tumor progression. The present findings determine potential biomarkers and therapeutic targets to improve OS prognosis and treatment.
Source: Discover Oncology
Author: Chunyang Wu
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,690
OpenAlex ID: W4411354144